Measles Virus Could Help Treat Head and Neck Cancer

Researchers from the Institute of Cancer Research (ICR) in London have discovered that an innovative new combination treatment that uses the measles virus to target cancer cells could significantly improve treatment for head and neck cancer.

A new study published in Radiotheraphy & Oncology finds that exposing cancer cells to a genetically modified measles virus, in conjunction with radioactive iodide, radiation treatment and gene-targeting drugs is more effective than using any of the treatments separately.

Although further research is required, we hope that the new treatment will be available soon to make a difference to people fighting with the disease.